Welcome to our dedicated page for Healthcare Svcs Group SEC filings (Ticker: HCSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare Services Group filings document the company’s operating results, segment performance, liquidity, and public-company governance. Recent 8-K filings furnish quarterly and annual earnings releases covering Environmental Services and Dietary Services revenue, margins, cash flow, share repurchases, and growth outlook commentary.
The company’s regulatory record also includes disclosure of a credit agreement amendment and related debt obligations, Regulation FD updates involving customer exposure, and proxy materials addressing board matters, executive compensation, equity awards, and shareholder voting items. These filings frame HCSG as a Pennsylvania-incorporated operating company serving healthcare facilities through outsourced housekeeping, laundry, dining, and nutritional services.
HEALTHCARE SERVICES GROUP INC executive Jason J. Bundick reported multiple equity award transactions. He acquired 3,374 Restricted Stock Units and related common shares through exercises and conversions at a stated price of $0.00 per share.
He also acquired blocks of 3,374 and 9,643 shares of common stock upon conversion at a 1-for-1 rate, while 1,432 and 4,091 shares of common stock were disposed of at $21.40 per share to satisfy tax withholding obligations. Certain common shares were earned from a performance stock unit award based on financial performance criteria and vested when the company’s compensation committee certified the results.
Healthcare Services Group Inc. executive Patrick J. Orr, EVP & Chief Revenue Officer, reported selling a total of 44,615 shares of common stock in open-market transactions on February 18, 2026. The sales were executed at prices of $20.55 and $20.52 per share, leaving him with no directly held shares reported after the transactions.
Healthcare Services Group Inc. executive Patrick J. Orr, EVP & Chief Revenue Officer, reported multiple stock option exercises and a share sale. On February 18, 2026, he exercised several stock option grants, lifting his direct common stock holdings to 90,115 shares before selling 45,500 shares in an open-market transaction at $20.54 per share, ending with 44,615 shares held directly.
Healthcare Services Group Inc EVP & Chief Admin. Officer John Christopher Shea reported multiple equity transactions in company stock. On February 18, 2026, he exercised stock options for 29,579 shares at $18.10 and 9,278 shares at $13.72, converting them into common stock. The filing also shows open-market sales of 15,500 common shares at $20.52 and 38,857 common shares at $20.36. Following these exercises and sales, his directly held common stock position is reported as 29,292 shares.
HEALTHCARE SERVICES GROUP INC President & CEO Theodore Wahl reported routine equity compensation activity in company common stock. On February 17, 2026, he acquired 8,511 shares at $20.93 per share as a grant under the annual incentive program, then disposed of 8,511 shares at $20.93 per share to cover related tax obligations through share withholding, a non‑open‑market transaction. After these transactions, directly held common stock was reported as 486,863 shares, and a footnote states total direct and indirect beneficial ownership of 604,210 shares.
HCSG executive files a Form 144 to sell common stock through Morgan Stanley Smith Barney LLC. The filing lists four blocks of common shares associated with different award types: 31,826 (restricted stock, 01/04/2019), 11,167 (employee stock purchase plan, 12/31/2017), 45,500 (stock option exercise, 02/18/2026), and 1,623 (performance shares, 02/24/2025).
Morgan Stanley Smith Barney LLC submitted a Form 144 notice to sell shares of HCSG. The filing lists multiple restricted stock grant lots by grant date and a stock option exercise of 38,857 shares dated 02/18/2026. The entries are listed as issuer-originated restricted awards and a cash exercise.
Mackenzie Financial Corporation reports beneficial ownership of 3,549,789 common shares of Healthcare Services Group Inc., representing 5.04% of the outstanding class. Mackenzie has sole power to vote and dispose of these shares, with no shared voting or dispositive power.
The ownership is reported on an amended Schedule 13G, filed as Amendment No. 11, with the reportable event dated 12/31/2025. Mackenzie states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Healthcare Services Group, Inc. reports 2025 results showing moderate growth with rising credit risk. Revenue increased 7.1% to $1,837.2 million, with Environmental Services contributing $824.7 million and Dietary $1,012.5 million. Net income rose 49.6% to $59.1 million, lifting net margin to 3.2%.
Profitability was helped by $34.2 million of Employee Retention Credit refunds and $5.3 million of related interest income. At the same time, credit issues intensified: bad debt provisions increased to $83.1 million, or 4.5% of revenue, including $63.9 million tied to Genesis Healthcare’s Chapter 11 bankruptcy, a customer that represented 7.3% of 2025 revenue.
The company served about 2,800 facilities at year-end, with labor and supply costs remaining the largest expense drivers across both segments. Management highlights ongoing inflation, tariff exposure, labor market pressures, customer financial health, cybersecurity risks and evolving healthcare and tax regulations as key risk factors for future results.
Healthcare Services Group, Inc. reported solid 2025 growth and boosted capital returns while outlining 2026 targets. Full-year revenue reached $1.84 billion, up 7.1%, with fourth-quarter revenue of $466.7 million, a 6.6% increase. Net income rose to $59.1 million for 2025 and $31.2 million in the fourth quarter, with diluted EPS of $0.81 for the year and $0.44 for the quarter.
Cash flow from operations was $145.0 million for 2025, or $164.1 million excluding payroll accrual changes. The company completed a $50.0 million buyback in 2025 and its board authorized repurchases of up to 10.0 million shares, with plans to repurchase $75.0 million of stock over 12 months. Management expects mid-single-digit revenue growth and targets 2026 cost of services in the 86% range and SG&A between 9.5% and 10.5%. Year-end liquidity included $203.9 million of cash and marketable securities plus an unused $300.0 million credit facility.